Pharmaceuticals, Biotechnology and Life Sciences
Hikma Pharmaceuticals PLC has completed acquisition of the Canadian assets of Teligent Inc. for $45.75 million. The acquisition marks Hikma’s…
Hikma Pharmaceuticals and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma), the world’s fourth largest specialty generic pharmaceutical company, announced today that they have entered into an exclusive licensing and distribution agreement for Ilumya, an innovative biologic product, for the Middle East and North Africa (MENA) region.
Hikma has submitted to the US Food and Drug Administration (FDA) its response to deficiencies in its abbreviated new drug application (ANDA) for a generic version of GlaxoSmithKline’s Advair Diskus® (fluticasone propionate and salmeterol inhalation powder).
Hikma Pharmaceuticals’s wholly owned US subsidiary West-Ward Pharmaceuticals, has launched Ritonavir Tablets USP, 100 mg, the first AB-rated generic to…
Hikma Pharmaceutical has delivered a solid performance in 2017 showing the benefit of our diversified business model, Said Darwazah, Executive Chairman…
Hikma Pharmaceuticals has appointed Sigurdur (Siggi) Olafsson as Chief Executive Officer (CEO), who will also join Hikma’s Board of Directors…
Hikma Pharmaceuticals’s US subsidiary West-Ward Pharmaceuticals has launched Ethacrynic Acid Tablets USP in 25mg strength, the generic equivalent to Edecrin (ethacrynic acid) for the treatment of edema when an agent with greater diuretic potential than those commonly employed is required.
Hikma Pharmaceuticals said on Friday that its US subsidiary West-Ward Pharmaceuticals Corp. has launched two doses of generic Pfizer’s Pristiq (Desvenlafaxine Succinate) ER Tablets.
Hikma Pharmaceuticals has signed an exclusive licensing and distribution agreement with Orion Corporation of Finland (Orion), for its new Easyhaler combination product, a dry powder inhaler (DPI) of budesonide and formoterol, for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Hikma Pharmaceuticals participated in the World Economic Forum (WEF) Annual Meeting in Davos, Switzerland, held between 17 and 20 January,…